@Kirsten:

Stimmt schon für den Verschluß des Rachens beim trinken ist das Gaumensegel entscheidend. Mit der Öffnung der Eustach'schen Röhre hat das aber nicht unbedingt etwas zu tun. Die Öffnung der Röhre hinter den Tubenwülsten sitzt ja an der Rachenhinterwand. der genaue Mechanismus und welche Muskel mittbelteiligt sind wird immer noch untersucht. Man vermutet auch das die knorpelige Hälfte der Röhre bei einigen Menschen fehl angelegt ist.

Und: Ärzte sind sich NIE einig.





Cleft Palate Craniofac J. 1998 Mar;35(2):101-10. Links

An anatomic study of the tensor veli palatini and dilatator tubae muscles in relation to eustachian tube and velar function.

Barsoumian R, Kuehn DP, Moon JB, Canady JW.
University of Rochester School of Medicine, New York, USA.
In a gross anatomic study of 20 sides in 16 human head specimens, the tensor veli palatini, the dilatator tubae, and the tensor tympani muscles were studied. The tensor veli palatini was observed to insert onto the anterior one-third of the pterygoid hamulus, whereas the dilatator tubae rounded the middle one-third of the pterygoid hamulus without an insertion. Thus, the dilatator tubae, not the tensor veli palatini, could serve to tense the anterior velum. An insertion from the superior pharyngeal constrictor muscle onto the posterior one-third of the hamulus could provide a curbing function for the dilatator tubae muscle. Adipose tissue, located at the hamulus, could provide lubrication for the tendinous fibers of the dilatator tubae as they round the hamulus. The dilatator tubae was observed to attach to the hook of the eustachian tube and is accepted as the tubal dilator. Observed on 13 of 20 sides in 11 specimens, the bulk of the dilatator tubae remained distinct from the tensor veli palatini despite a connective tissue alliance and intermingling of some muscle fibers. On 5 of 20 sides in 5 specimens, fibers of the dilatator tubae intermingled extensively with the tensor veli palatini. Of the 20 dilatator tubae muscles dissected, 2 were observed to be deficient. The tensor veli palatini was observed to be continuous with the tensor tympani.


Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic.

Isaacson G, Buttaro BA, Mazeffa V, Li G, Frenz DA.
Dept of Otolaryngology-Head and Neck Surgery, Temple University School of Medicine, 3400 North Broad St, Philadelphia, PA 19140, USA.
OBJECTIVES: This study was performed to explore the antimicrobial activity of two commercially available oxymetazoline hydrochloride preparations against the common pathogens of otitis media and to demonstrate the lack of ototoxicity of these agents and of United States Pharmacopeia (USP) oxymetazoline in a standard animal model. METHODS: Disc diffusion assays and minimum inhibitory concentration studies against American Type Culture Collection reference strains of common middle ear pathogens were used to evaluate the antimicrobial activity of oxymetazoline solutions and fluoroquinolone drops, and outer hair cell counts were performed on scanning electron micrographs of guinea pig basal cochlear segments after chronic exposure to oxymetazoline solutions and positive and negative controls. RESULTS: Oxymetazoline nasal spray and eyedrops had activity against all species tested except Haemophilus influenzae and Pseudomonas aeruginosa. The USP oxymetazoline had limited antimicrobial activity. Oxymetazoline nasal spray, oxymetazoline eyedrops, and USP oxymetazoline had ototoxicity profiles indistinguishable from that of the saline solution control. CONCLUSIONS: Commercially available oxymetazoline solutions are active against several of the common pathogens of otitis media. This antimicrobial activity is not due to oxymetazoline, and is more likely due to preservatives present in the solutions. The solutions tested are not ototoxic to guinea pig outer hair cells. Oxymetazoline solutions are potential substitutes for broad-spectrum antibiotic drops after tympanostomy tube placement.
PMID: 16190099 [PubMed - indexed for MEDLINE]